HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xing Xie Selected Research

Invasive Hydatidiform Mole (Invasive Mole)

7/2011[Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
6/2005Mismatch repair gene promoter methylation and expression in hydatidiform moles.
4/2005PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles.
8/2003[Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xing Xie Research Topics

Disease

65Neoplasms (Cancer)
05/2022 - 04/2002
40Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 02/2006
34Carcinoma (Carcinomatosis)
01/2014 - 01/2002
29Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2003
24Ovarian Epithelial Carcinoma
01/2022 - 05/2004
16Neoplasm Metastasis (Metastasis)
03/2022 - 04/2002
13Carcinogenesis
01/2021 - 01/2002
9Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
04/2022 - 08/2003
9Adenocarcinoma
01/2021 - 07/2009
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 04/2005
8Infections
06/2021 - 03/2014
8Uterine Cervical Dysplasia
01/2021 - 05/2010
7Choriocarcinoma
01/2022 - 06/2004
7Ascites
01/2020 - 04/2002
7Hydatidiform Mole (Molar Pregnancy)
03/2019 - 08/2003
6Body Weight (Weight, Body)
11/2021 - 08/2005
5Lymphatic Metastasis
01/2021 - 04/2005
5Endometrial Neoplasms (Endometrial Cancer)
09/2014 - 01/2002
4Breast Neoplasms (Breast Cancer)
07/2021 - 01/2007
4Papillomavirus Infections
01/2021 - 08/2009
4Atypical Squamous Cells of the Cervix
08/2011 - 05/2010
4Invasive Hydatidiform Mole (Invasive Mole)
07/2011 - 08/2003
4Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
11/2005 - 01/2002
3Squamous Intraepithelial Lesions
10/2017 - 05/2010
2Disease Progression
01/2022 - 12/2012
2Obesity
11/2021 - 02/2016
2Virus Diseases (Viral Diseases)
06/2021 - 01/2021
2Pneumonia (Pneumonitis)
01/2021 - 01/2021
2Persistent Infection
12/2019 - 01/2016
2Cysts
04/2019 - 07/2008
2Leukemia
03/2017 - 03/2016
2Hyperplasia
09/2014 - 01/2002
2Residual Neoplasm
01/2014 - 11/2010

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
03/2022 - 04/2002
12Messenger RNA (mRNA)IBA
05/2022 - 01/2002
12DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2003
11MicroRNAs (MicroRNA)IBA
11/2021 - 08/2011
10Methotrexate (Mexate)FDA LinkGeneric
04/2022 - 08/2003
10Paclitaxel (Taxol)FDA LinkGeneric
11/2019 - 08/2005
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2010 - 01/2002
8CytokinesIBA
06/2016 - 04/2003
7Biological ProductsIBA
03/2021 - 05/2002
7Small Interfering RNA (siRNA)IBA
11/2019 - 04/2010
7AntigensIBA
01/2019 - 05/2002
6Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2002
6Oncogene Proteins (Oncogene Protein)IBA
12/2016 - 03/2009
6ParaffinIBA
12/2014 - 08/2003
6Interleukin-10 (Interleukin 10)IBA
11/2009 - 02/2004
5Peptides (Polypeptides)IBA
05/2022 - 06/2004
5PlatinumIBA
01/2022 - 11/2003
4Pharmaceutical PreparationsIBA
09/2021 - 11/2010
4VaccinesIBA
01/2021 - 11/2009
4AntibodiesIBA
05/2020 - 04/2006
4TeaIBA
03/2017 - 11/2004
4EnzymesIBA
03/2016 - 05/2004
3Circular RNAIBA
05/2022 - 12/2020
3Dactinomycin (Actinomycin)FDA LinkGeneric
04/2022 - 07/2007
3RNA (Ribonucleic Acid)IBA
01/2021 - 09/2016
3Protein Isoforms (Isoforms)IBA
12/2020 - 01/2002
3Fibrinogen (Factor I)FDA Link
01/2020 - 10/2008
3Carboplatin (JM8)FDA LinkGeneric
11/2019 - 08/2005
3LuteinIBA
04/2019 - 01/2007
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2019 - 01/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2016 - 08/2005
3Coloring Agents (Dyes)IBA
03/2014 - 07/2007
3Complementary DNA (cDNA)IBA
04/2011 - 04/2003
3telomerase RNA (bTR)IBA
01/2011 - 05/2010
3Interleukin-4 (Interleukin 4)IBA
12/2009 - 04/2009
3Interleukin-2 (IL2)IBA
11/2005 - 02/2004
3Phosphates (Orthophosphate)IBA
09/2004 - 04/2002
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 09/2021
2olaparibIBA
01/2022 - 09/2021
2Estrogen ReceptorsIBA
05/2021 - 06/2005
2CalciumIBA
05/2021 - 09/2003
2Long Noncoding RNAIBA
03/2021 - 12/2020
2Glucose (Dextrose)FDA LinkGeneric
02/2021 - 12/2020
2Virulence Factors (Pathogenicity Factors)IBA
01/2021 - 01/2019
2Papillomavirus Vaccines (HPV Vaccines)IBA
01/2021 - 12/2019
2Hormones (Hormone)IBA
05/2020 - 08/2009
2Cisplatin (Platino)FDA LinkGeneric
08/2018 - 07/2007
2Interferon-gamma (Interferon, gamma)IBA
06/2016 - 03/2003
2Oxidoreductases (Dehydrogenase)IBA
03/2016 - 05/2013
2Cadherins (E-Cadherin)IBA
01/2016 - 01/2013
2Glycogen Synthase (Synthase I)IBA
01/2014 - 04/2011
2Glycogen Synthase Kinase 3IBA
01/2014 - 04/2011
2Formaldehyde (Formol)FDA Link
04/2013 - 07/2010
2Tyrosine (L-Tyrosine)FDA Link
01/2013 - 02/2004
2HLA-DR Antigens (HLA-DR)IBA
12/2012 - 04/2006
2Leukemia Inhibitory FactorIBA
11/2009 - 04/2009
2Transforming Growth Factor beta (TGF-beta)IBA
11/2009 - 08/2007
2Codon (Codons)IBA
08/2009 - 06/2009
2ImmunosorbentsIBA
04/2009 - 05/2004

Therapy/Procedure

21Therapeutics
05/2022 - 02/2005
17Drug Therapy (Chemotherapy)
04/2022 - 08/2003
7Lymph Node Excision (Lymph Node Dissection)
11/2020 - 04/2005
6Neoadjuvant Therapy
01/2017 - 02/2006
6Hysterectomy
03/2013 - 01/2002
5Curettage
10/2018 - 01/2002
3Transplantation
09/2004 - 05/2002
2Conservative Treatment
09/2010 - 01/2010